Precision Medicine Group’s Post

Clinical trials don’t always end in cures. But Victoria Gordon, Senior Clinical Research Associate, Precision For Medicine, believes in the power of the hope they offer to patients and their families. It’s a lesson she learned watching her mother and it informs her work on #oncology trials every day. WATCH HER STORY. #bcam2024 #breastcancerawarenessmonth #cancerscreening #breastcancersurvival #healthcare #oncolog

Discrimination? Imposter syndrome? Work-life balance struggles? This panel of extraordinary women leaders has been there, done that, and are ready to share their wisdom. Hosted by Endpoints News, this panel will bring real stories of strife and success to ignite your ambition and propel your career forward. https://lnkd.in/e3fn8VPn #WomenInBiopharma2024 #CareerGrowth #LeadershipInsights #WomenInScience

At Precision, helping our partners advance cancer care is core to our mission. Yet, for many of us, the drive to cure breast cancer is also personal. That's why each October, in honor of Breast Cancer Awareness Month, we share team member stories, spread knowledge, and raise money to fight breast cancer through our company-wide Precision in Pink initiative. Breast cancer is the world’s most common cancer. Swipe through our fact sheet to see startling statistics and important information on risk factors and warning signs. #bcam2024 #breastcancerawarenessmonth #cancerscreening #breastcancersurvival #healthcare #oncology

Today, we are excited to welcome Margaret Keegan (Margaret K.) as our Chief Executive Officer! Margaret is a passionate leader, with over thirty years of relevant, life sciences experience and a deep commitment to our foundational principles, as well as our patient-centric and client-first approach. Margaret’s vision and extensive industry knowledge will be instrumental as she leads us through our next stage of growth, and we continue to support life sciences organizations in bridging the gap between science and health, by accelerating the development of biomedical innovation and ensuring widespread access to new, breakthrough therapies. Welcome to the team, Margaret! Read more in our press release: https://lnkd.in/e6XSNSPD “PMG was among the first to recognize the power of more personalized, targeted therapies to deliver better outcomes, and early to identify the possibilities and challenges that precision medicine-based approaches would introduce from clinical development through commercialization," says Margaret. "In many ways, our industry is at a similar inflection point now, as we assimilate innovations in technology and artificial intelligence and respond to new regulations and shifting macroeconomic conditions. This introduces a tremendous opportunity for PMG to advance from being the first mover in precision medicine to being the global expert in drug development and commercialization. I am thrilled to be joining Precision at this exciting point in the company’s rapid development and look forward to leading this outstanding team of professionals.”

Their journey had no shortcuts—from bench to board room, meet the women paving the way for the next generation of life science leaders. https://hubs.ly/Q02Rg10S0 #WomenInBiopharma2024 #lifesciences

When we talk about our life changing work, we're not just talking about patients, we're also talking about you. Moving a molecule to market can change the lives of the innovators we support—and patients in need. See how in the video and on our new website. https://hubs.ly/Q02R4rBT0

🚨 Major Collaboration Update! Precision for Medicine is working with SOPHiA GENETICS and Boundless Bio to revolutionize clinical trials with their novel platform. Precision for Medicine helped validate a novel assay to enable advanced diagnostic workflows for Boundless Bio’s POTENTIATE trial, expediting patient selection for ecDNA-driven cancer therapies. Read more about the partnership and breakthrough on the Precision for Medicine press release! https://hubs.ly/Q02QJ0gt0? #precisionmedicine #clinicaltrials #datadrivenmedicine #SOPHiAGenetics #BoundlessBio

In this article published by Citeline's Pink Sheet, Project Farma (PF)'s Anshul Mangal provides key insights on how potential US restrictions on Chinese clinical trials could disrupt global biopharma operations and lead to increased costs. Click here to read more: https://hubs.ly/Q02QqCVD0 #USChinaRelations #Clinicaltrials #drugdevelopment #supplychain #patientfocused #biopharma